AFFINITY ASSET ADVISORS, LLC 13F Portfolio
AFFINITY ASSET ADVISORS, LLC runs AFFINITY ASSET ADVISORS, LLC and currently holds 113 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $2.21B. Their top holdings are ROIV, APGE, SYRE, XENE, ERAS. The top five represent 25.8% of reported portfolio weight. AFFINITY ASSET ADVISORS, LLC ranks #117 out of 1000 investors tracked by Alpha Score. In the most recent quarter, AFFINITY ASSET ADVISORS, LLC initiated 4 new positions. They added to 13 existing positions. They trimmed 18 positions. Their current best-performing preview position is CMPS with returns of +155.88%.
Portfolio Value
$2.21B
Alpha Score
121.0
#117 of 1000
Holdings
113
AFFINITY ASSET ADVISORS, LLC Current 13F Holdings
Reported holdings from AFFINITY ASSET ADVISORS, LLC's latest SEC 13F filing, ranked by portfolio weight.
113 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 ROIV ROIVANT SCIENCES LTD | 6.00% | $25.07 | $35.44 | +41.36% | Added +33.93% |
 APGE APOGEE THERAPEUTICS INC | 5.92% | $40.36 | $135.07 | +234.66% | Trimmed -23.19% |
 SYRE SPYRE THERAPEUTICS INC | 5.13% | $18.01 | $85.69 | +375.79% | Held |
 XENE XENON PHARMACEUTICALS INC | 4.35% | $44.05 | $36.44 | -17.28% | Trimmed -4.78% |
 ERAS ERASCA INC | 4.35% | $5.85 | $16.03 | +174.02% | Trimmed -1.87% |
 INSM INSMED INC | 3.13% | $99.41 | $100.60 | +1.20% | Added +35.42% |
 PRAX PRAXIS PRECISION MEDICINES I | 2.80% | $297.99 | $259.86 | -12.80% | Added +8.82% |
 ALKS ALKERMES PLC | 2.66% | $29.12 | $40.61 | +39.46% | Trimmed -16.67% |
 ORKA ORUKA THERAPEUTICS INC | 2.54% | $30.68 | $82.11 | +167.63% | Added +18.08% |
 ANAB ANAPTYSBIO INC | 2.52% | $34.77 | $45.95 | +32.15% | Trimmed -12.12% |
Showing 1-10 of 113